Type 2 diabetes trials in South Korea

In South Korea 66 Also abroad 1245

66 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in South Korea
CGM-Based Glycemic Analysis After ESI
Where
Seoul
Age
20 years to 60 years
People
36
Run by
Korea University Anam Hospital
See details and how to joinNCT07280780
No phaseTaking people
Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
Where
Seoul
Age
20 years to 69 years
People
120
Run by
Korea University Anam Hospital
See details and how to joinNCT04284943
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Bucheon-si, Gyeonggi-do, Jongno-gu, Junggu, Seoul
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
Phase 4Taking people
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Where
Seongnam-si
Age
19 years and over
People
1,200
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT07719894
No phaseEnrolling by invitation
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
Where
Seoul
Age
19 years and over
People
800,000
Run by
Novo Nordisk A/S
See details and how to joinNCT07673822
Phase 3Not yet taking people in South Korea
To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
Where
Seoul
Age
18 years to 80 years
People
510
Run by
Daewoong Pharmaceutical Co. LTD.
See details and how to joinNCT07619833
Phase 3Taking people
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Where
Gyeonggi-do
Age
19 years and over
People
118
Run by
Hanmi Pharmaceutical Company Limited
See details and how to joinNCT07379333
Phase 4Taking people
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Where
Seongnam-si
Age
20 years and over
People
56
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05365425
Phase 4Taking people
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Where
Seongnam-si
Age
20 years to 80 years
People
105
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05365438
No phaseEnrolling by invitation
Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
Where
Jeonlabuk-do
Age
19 years and over
People
600
Run by
Novo Nordisk A/S
See details and how to joinNCT05689372
Phase 4Taking people
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis
Where
Seongnam-si
Age
20 years to 80 years
People
120
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06399835
Phase 4Taking people
Clopidogrel Versus Cilostazol on Vessels
Where
Seongnam-si
Age
19 years and over
People
120
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT06402747
Phase 3Taking people
Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
Where
Seoul
Age
19 years and over
People
228
Run by
Hanlim Pharm. Co., Ltd.
See details and how to joinNCT07552389
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Busan, Goyang-si, Gyeonggi-do, Seoul
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseTaking people
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
Where
Seoul
Age
70 years and over
People
2,186
Run by
Sin Gon Kim
See details and how to joinNCT07359105
Phase 4Taking people
Glycemic Variability of Combination Therapies in T2DM
Where
Seoul
Age
19 years and over
People
178
Run by
JW Pharmaceutical
See details and how to joinNCT07442006
Phase 4Not yet taking people in South Korea
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Where
Seoul
Age
19 years and over
People
200
Run by
Chong Kun Dang Pharmaceutical
See details and how to joinNCT07365358
Phase 3Taking people
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Where
Anyang, Buchon, Busan, Cheonan, Daegu, Daejeon, Goyang-si, Guri-si, Gwangju, Iksan, Inchon, Jeonju, Seongnam, Seoul, Suwon, Wŏnju, Yongin-si
Age
19 years to 80 years
People
240
Run by
CMG Pharmaceutical Co. Ltd
See details and how to joinNCT06772168
No phaseTaking people
Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use
Where
Seoul
Age
19 years to 80 years
People
150
Run by
Kangbuk Samsung Hospital
See details and how to joinNCT07336329
Phase 2Not yet taking people in South Korea
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Where
Seoul
Age
19 years and over
People
288
Run by
Dong-A ST Co., Ltd.
See details and how to joinNCT07239440
No phaseTaking people
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Where
Incheon
Age
19 years and over
People
9,000
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT05970237
Phase 4Taking people
A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
Where
Seoul
Age
19 years and over
People
204
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06972732
Phase 4Taking people
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
Where
Seoul
Age
20 years to 79 years
People
30
Run by
Korea University Anam Hospital
See details and how to joinNCT06782139
Phase 3Taking people
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Where
Seoul
Age
19 years and over
People
171
Run by
Celltrion
See details and how to joinNCT07093476
Phase 4Not yet taking people in South Korea
Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors
Where
Seoul
Age
19 years to 75 years
People
100
Run by
Yonsei University
See details and how to joinNCT07108985